Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans.
about
Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults.Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.Development of biliary sludge in patients on intensive care unit: results of a prospective ultrasonographic study.Lactobacillus rhamnosus lowers zebrafish lipid content by changing gut microbiota and host transcription of genes involved in lipid metabolism.Gallstones: an intestinal disease?Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice.Gall stones and gall bladder motility.Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy.The mechanism of enterohepatic circulation in the formation of gallstone disease.Effect of intravenous amino acids on interdigestive antroduodenal motility and small bowel transit time.The effects of short term lipid infusion on plasma and hepatic bile lipids in humansLack of endogenous cholecystokinin promotes cholelithogenesis in miceTargeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis.Complications and monitoring - Guidelines on Parenteral Nutrition, Chapter 11.Complications of enterocutaneous fistulas and their management.Endogenous elevation of plasma cholecystokinin does not prevent gallstones.Sphincterotomy and the gall bladder--a slice of luck.The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
P2860
Q30402581-44E8D79C-DF5D-46E6-A786-ADCDD688217CQ30487910-6079E60B-6245-41DB-B3D8-796782E95870Q30498435-E0D74768-E4E8-49A5-9372-EC4AC86FD927Q30633324-9EF215A3-11D0-4A3B-9C73-7DE7391B496AQ33534712-CFD12C91-2E1C-4B96-9914-B737BDFF6CFEQ33698042-299B1FDC-3871-4313-84FC-6E29E87B3635Q34377137-AFFD5B72-A981-4621-9EFA-62B6F28EE65CQ34377435-40F15F52-9F3D-49DD-8B65-9CAFA821A715Q34396525-718DA63D-3911-4343-987C-71267C5B64C3Q35353838-781AC59D-595D-4640-8CA5-ED5A0B261193Q35356846-25F01076-3963-42D3-831B-0679BA7B0936Q36599375-A096671C-57FD-458B-9FD6-24491A7C3A25Q37286178-B4F56FBD-9326-4EA5-9AC9-2ED4883F023FQ37481675-5E3557F5-99B4-4389-8ACC-4228704FE700Q37925493-EE994EB8-85FC-4FE8-AF49-0896E5120817Q43164937-FB88CFCD-E255-4C15-8530-EA19E091BD5DQ43226533-EE94A6EF-DA7A-4112-A0A8-858DDAC42652Q51292343-353963C6-1FA0-4734-B523-9898A7F90559
P2860
Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans.
@en
type
label
Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans.
@en
prefLabel
Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans.
@en
P2093
P1476
Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans.
@en
P2093
P577
1990-01-01T00:00:00Z